Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10 - A role for IL-1β?

Journal of Neurochemistry

Volumn 88, Issue 3, 2004, Pages 635-646

  Lynch, Aileen M ^a   Walsh, Christine ^a   Delaney, Ada ^a   Nolan, Yvonne ^a   Campbell, Veronica A ^a   Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cell death; Hippocampus; IL 1 ; IL 10; Lipopolysaccharide; Long term potentiation

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWNSTREAM PROCESSING; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INHIBITION KINETICS; LONG TERM POTENTIATION; MALE; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-10; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; LONG-TERM POTENTIATION; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; UP-REGULATION;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0942276786     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02157.x     Document Type: Article

References (69)

1. Agnello D., Villa P. and Ghezzi P. (2000) Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice. Brain Res. 869, 241-243.
2. Bachis A., Colangelo A. M., Vicini S., Doe P. P., De Bernardi M. A., Brooker G. and Mocchetti I. (2001) Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 21, 3104-3112.
3. Bellinger F. P., Madamba S. and Siggins G. R. (1993) Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628, 227-234.
4. Bluthe R. M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., Michaud B., Kelley K. W. and Dantzer R. (1999) Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 3, 301-311.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
6. Bromberg J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C. and Darnell J. E. Jr (1999) Stat3 as an oncogene. Cell 98, 295-303.
7. Cao Z., Xiong J., Takeuchi M., Kurama T. and Goeddel D. V. (1996) TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446.
8. Cunningham A. J., Murray C. A., O'Neill L. A. J., Lynch M. A. and O'Connor J. J. (1996) Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203, 17-20.
9. Di Santo E., Sironi M., Pozzi P., Gnocchi P., Isetta A. M., Delvaux A., Goldman M., Marchant A. and Ghezzi P. (1995) Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1β production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. Neuroimmuno-modulation 2, 149-154.
10. Di Santo E., Adami M., Bertorelli R. and Ghezzi P. (1997) Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice. Eur. J. Pharmacol. 336, 197-202.
11. Durez P., Abramowicz D., Gerard C., Van Mechelen M., Amraoui Z., Dubois C., Leo O., Velu T. and Goldman M. (1993) In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J. Exp. Med. 177, 551-555.
12. Fiorentino D. F., Zlomik A., Mosmann T. R., Howard M. and O'Garra A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
13. Grilli M., Barbieri I., Basudev H., Brusa R., Casati C., Lozza G. and Ongini E. (2000) Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 12, 2265-2272.
14. Guha M. and Mackman N. (2001) LPS induction of gene expression in human monocytes. Cell Signal. 13, 85-94.
15. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P. and Thompson R. C. (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343, 336-340.
16. Hu J., Jacinto R., McCall C. and Li L. (2002) Regulation of IL-1 receptor-associated kinases by lipopolysaccharide. J. Immunol. 168, 3910-3914.
17. Ilyin S. E. and Plata-Salaman C. R. (1996a) In vivo regulation of the IL-1β system (ligand, receptors I and II, receptor accessory protein, and receptor antagonist) and TNF-α mRNAs in specific brain regions. Biochem. Biophys. Res. Commun. 227, 861-867.
18. Ilyin S. E. and Plata-Salaman C. R. (1996b) Molecular regulation of the brain interleukin-1β system in obese (fa/fa) and lean (Fa/Fa) Zucker rats. Brain Res. Mol. Brain Res. 43, 209-218.
19. Ilyin S. E., Gayle D., Flynn M. C. and Plata-Salaman C. R. (1998) Interleukin-1β system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-α, TGF-β1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res. Bull. 45, 507-515.
20. Kawasaki M., Kuwano K., Hagimoto N., Matsuba T., Kunitake R., Tanaka T., Maeyama T and Hara N. (2000) Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am. J. Pathol. 157, 597-603.
21. Kelly A., Lynch A., Vereker E., Nolan Y., Queenan P., Whittaker E., O'Neill L. A. J. and Lynch M. A. (2001) The anti-inflammatory cytokine, IL-10, blocks the inhibitory effect of IL-1β on LTP: a role for JNK. J. Biol. Chem. 276, 45564-45572.
22. Kelly A., Vereker E., Nolan Y., Brady M., Barry C., Loscher C. E., Mills K. H. and Lynch M. A. (2003) Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1β on long-term potentiation in rat dentate gyrus. J. Biol. Chem. 278, 19453-19462.
23. Koprak S., Staruch M. J. and Dumont F. J. (1999) A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. 192, 87-95.
24. Laflamme N. and Rivest S. (2001) Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15, 155-163.
25. Ledeboer A., Binnekade R., Brevé J. J., Bol J. G., Tilders F. J. and Van Dam A. M. (2002a) Site-specific modulation of LPS-induced fever and interleukin-1β expression in rats by interleukin-10. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1762-R1772.
26. Ledeboer A., Brevé J. J., Wierinckx A., van der Jagt S., Bristow A. F., Leysen J. E., Tilders F. J. and Van Dam A. M. (2002b) Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 16, 1175-1185.
27. Leon L. R., Kozak W., Rudolph K. and Kluger M. J. (1999) An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 276, R81-R89.
28. Li L., Cousart S., Hu J. and McCall C. E. (2000) Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275, 23340-23345.
29. Lonergan P. E., Martin D. S., Horrobin D. F. and Lynch M. A. (2002) Neuroprotective effect of eicosapentanoic acid in hippocampus of rats exposed to gamma irradiation. J. Biol. Chem. 277, 20804-20811.
30. Luo Y., Umegaki H., Wang X., Abe R. and Roth G. S. (1998) Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem. 273, 3756-3764.
31. Lynch A. M. and Lynch M. A. (2002) The age-related increase in IL-1 Type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur. J. Neurosci. 15, 1779-1788.
32. Ma W., Lim W., Gee K., Aucoin S., Nandan D., Kozlowski M., Diaz-Mitoma F. and Kumar A. (2001) The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276, 13664-13674.
33. Maroney A. C., Glicksman M. A., Basma A. N. et al. (1998) Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18, 104-111.
34. McGahon B. and Lynch M. A. (1996) The synergism between metabotropic glutamate receptor activation and arachidonic acid on glutamate release is occluded by induction of long-term potentiation in the dentate gyrus. Neuroscience 72, 847-855.
35. Minogue A. M., Schmid A. W., Fogarty M. P., Moore A. C., Campbell V. A., Herron C. E. and Lynch M. A. (2003) Activation of the JNK signalling cascade mediates the effect of Aβ on LTP and cell death in hippocampus: a role for IL-1β. J. Biol. Chem. 278, 27971-27980.
36. Molina-Holgado E., Vela J. M., Arevalo-Martin A. and Guaza C. (2001) LPS/IFN-γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 13, 493-502.
37. Murray C. and Lynch M. A. (1998a) Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18, 2974-2981.
38. Murray C. and Lynch M. A. (1998b) Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J. Biol. Chem. 273, 12161-12168.
39. Nagano S., Otsuka T., Niiro H. et al. (2002) Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines. Int. Immunol. 14, 733-740.
40. Netea M. G., Kullberg B. J., Joosten L. A., Sprong T., Verschueren I., Boerman O. C., Amiot F., van den Berg W. B. and Van der Meer J. W. (2001) Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur. J. Immunol. 31, 2529-2538.
41. Niiro H., Otsuka T., Ogami E., Yamaoka K., Nagano S., Akahoshi M., Nakashima H., Arinobu Y., Izuhara K. and Niho Y. (1998) MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem. Biophys. Res. Commun. 250, 200-205.
42. O'Brien M. A., Moravec R. A. and Riss T. L. (2001) Poly (ADP-ribose) polymerase cleavage monitored in situ in apoptotic cells. Biotechniques 30, 886-891.
43. O'Donnell E., Vereker E. and Lynch M. A. (2000) Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. Eur. J. Neurosci. 12, 345-352.
44. O'Neill L. A. J. and Dinarello C. A. (2000) The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21, 206-209.
45. Pahan K., Khan M. and Singh I. (2000) Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase. J. Neurochem. 75, 576-582.
46. Park D. S., Stefanis L., Yan C. Y., Farinelli S. E. and Greene L. A. (1996) Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J. Biol. Chem. 271, 21898-21905.
47. Pousset F., Cremona S., Dantzer R., Kelley K. W. and Parnet P. (2001) IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1β-activated mouse primary astrocytes. J. Neurochem. 79, 726-736.
48. Quan N., Sundar S. K. and Weiss J. M. (1994) Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49, 125-134.
49. Rady P. L., Smith E. M., Cadet P., Opp M. R., Tyring S. K. and Hughes T. K. Jr (1995) Presence of interleukin-10 transcripts in human pituitary and hypothalamus. Cell. Mol. Neurobiol. 15, 289-296.
50. Reiling N., Blumenthal A., Flad H. D., Ernst M. and Ehlers S. (2001) Mycobacteria-induced TNF-α and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol. 167, 3339-3345.
51. Riley J. K., Takeda K., Akira S. and Schreiber R. D. (1999) Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274, 16513-16521.
52. Rojas M., Olivier M., Gros P., Barrera L. F. and Garcia L. F. (1999) TNF-α and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol. 162, 6122-6131.
53. Saleshando G. and O'Connor J. J. (2000) SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus. Neurosci. Lett. 288, 119-122.
54. Schmidt A., Caron E. and Hall A. (2001) Lipopolysaccharide-induced activation of β2-integrin function in macrophages requires Irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase. Mol. Cell Biol. 21, 438-448.
55. Sheng W. S., Hu S., Kravitz F. H., Peterson P. K. and Chao C. C. (1995) Tumor necrosis factor α upregulates human microglial cell production of interleukin-10 in vitro. Clin. Diagn. Lab. Immunol. 2, 604-608.
56. Sims J. E., Gayle M. A., Slack J. L., Alderson M. R., Bird T. A., Giri J. G., Colotta F., Re F., Mantovani A. and Shanebeck K. (1993) Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl Acad. Sci. USA 90, 6155-6159.
57. Son Y. S., Park H. J., Kwon O. B., Jung S. C., Shin H. C. and Lim S. (2002) Antipyretic effects of acupuncture on the lipopolysaccharide-induced fever and expression of interleukin-6 and interleukin-1β mRNAs in the hypothalamus of rats. Neurosci. Lett. 319, 45-48.
58. Strle K., Zhou J. H., Broussard S. R., Venters H. D., Johnson R. W., Freund G. G., Dantzer R. and Kelley K. W. (2002) IL-10 promotes survival of microglia without activating Akt. J. Neuroimmunol. 122, 9-19.
59. Swantek J. L., Tsen M. F., Cobb M. H. and Thomas J. A. (2000) IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164, 4301-4306.
60. Van Dam A. M., Poole S., Schultzberg M., Zavala F. and Tilders F. J. (1998) Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 α, β, and receptor antagonist in rat brain. Ann. NY Acad. Sci. 840, 128-138.
61. Van der Poll T., Jansen J., Levi M., ten Cate H., ten Cate J. W. and van Deventer S. J. (1994) Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180, 1985-1988.
62. Vereker E., Campbell V., Roche E., McEntee E. and Lynch M. A. (2000a) Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 275, 6252-26528.
63. Vereker E., O'Donnell E. and Lynch M. A. (2000b) The inhibitory effect of interleukin-1β on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20, 6811-6819.
64. Wang P., Wu P., Siegel M. I., Egan R. W. and Motasim Billah M. (1994) IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153, 811-816.
65. Wang J. Y., Yang J. M., Wang J. Y., Tao P. L. and Yang S. N. (2001) Synergistic apoptosis induced by bacterial endotoxin lipopolysaccharide and high glucose in rat microglia. Neurosci. Lett. 304, 177-180.
66. Wong M. L., Bongiomo P. B., Rettori V., McCann S. M. and Licinio J. (1994) Interleukin (IL)-1β, IL-1 receptor antagonist, IL-10 and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc. Natl Acad. Sci. USA 90, 227-232.
67. Yanagisawa K., Tago K., Hayakawa M., Ohki M., Iwahana H. and Tominaga S. (2003) A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-κB (NF-κB) and c-Jun N-terminal kinase (JNK). Biochem. J. 370, 159-166.
68. Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincon M., Zheng T. S., Davis R. J., Rakic P. and Flavell R. A. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
69. Yoon D. Y. and Dinarello C. A. (1998) Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J. Immunol. 160, 3170-3179.